Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Features

Features Top 100 Agencies 2015: Intouch Solutions

Top 100 Agencies 2015: Intouch Solutions

Digital prowess drives this Kansas City-based agency toward the $100-million mark

Features Top 100 Agencies 2015: Infuse Medical

Top 100 Agencies 2015: Infuse Medical

Going deeper with existing clients

Features Top 100 Agencies 2015: HLG Communications

Top 100 Agencies 2015: HLG Communications

Reinventing to offer more to clients

Features Top 100 Agencies 2015: Heartbeat Ideas & Heartbeat West

Top 100 Agencies 2015: Heartbeat Ideas & Heartbeat West

A transition year wrought rejuvenation

Features Top 100 Agencies 2015: Healthcare Regional Marketing

Top 100 Agencies 2015: Healthcare Regional Marketing

A market-specific approach resonates

Features Top 100 Agencies 2015: HCB Health

Top 100 Agencies 2015: HCB Health

Hello, Chicago! says an Austin agency

Features Top 100 Agencies 2015: Havas Life New York

Top 100 Agencies 2015: Havas Life New York

Diversifying breeds happiness

Features Top 100 Agencies 2015: Havas Lynx

Top 100 Agencies 2015: Havas Lynx

Evolving from a digitally focused shop into a full-service agency

Features Top 100 Agencies 2015: Havas Life Metro

Top 100 Agencies 2015: Havas Life Metro

Efforts to diversify roster

Features Top 100 Agencies 2015: Harrison and Star

Top 100 Agencies 2015: Harrison and Star

Looking at pharma from the inside out

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.